EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Themis: advancing precision oncology through comprehensive molecular subtyping and optimization

Yue Xi, Kun Zheng iD, Fulan Deng, Yujun Liu, Hourong Sun, Yingxia Zheng, Henry H Y Tong, Yuan Ji, Yingchun Zhang, Wantao Chen, Yiming Zhang, Xin Zou und 1 weitere

Briefings in Bioinformatics · 23.05.2024 · 25 (4)

DOI: 10.1093/bib/bbae261 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Briefings in Bioinformatics, online erschienen am 04.06.2024. Verfasst von Yue Xi und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Reproductive Medicine, Central Hospital Affiliated to Shandong First Medical University, Jinan, Shandong Province, 250013, China. Hauptthemen laut MEDLINE: Precision Medicine. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, Innovative Research Team of High-level Local Universities in Shanghai.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recent advances in tumor molecular subtyping have revolutionized precision oncology, offering novel avenues for patient-specific treatment strategies. However, a comprehensive and independent comparison of these subtyping methodologies remains unexplored. This study introduces ‘Themis’ (Tumor HEterogeneity analysis on Molecular subtypIng System), an evaluation platform that encapsulates a few representative tumor molecular subtyping methods, including Stemness, Anoikis, Metabolism, and pathway-based classifications, utilizing 38 test datasets curated from The Cancer Genome Atlas (TCGA) and significant studies. Our self-designed quantitative analysis uncovers the relative strengths, limitations, and applicability of each method in different clinical contexts. Crucially, Themis serves as a vital tool in identifying the most appropriate subtyping methods for specific clinical scenarios. It also guides fine-tuning existing subtyping methods to achieve more accurate phenotype-associated results. To demonstrate the practical utility, we apply Themis to a breast cancer dataset, showcasing its efficacy in selecting the most suitable subtyping methods for personalized medicine in various clinical scenarios. This study bridges a crucial gap in cancer research and lays a foundation for future advancements in individualized cancer therapy and patient management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Precision MedicineHumansNeoplasmsBiomarkers, TumorComputational BiologyMedical OncologyBreast NeoplasmsFemale

Stichwörter der Autor:innen

benchmark testingbioinformaticspan-cancertumor subtyping

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Reproductive Medicine, Central Hospital Affiliated to Shandong First Medical University, Jinan, Shandong Province, 250013, China.
  • Institute of Clinical Science, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Department of Urology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200233, China.
  • School of Materials Science and Engineering, Shanghai Institute of Technology, Shanghai 201418, China.
  • Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Fudan University, Shanghai, China.
  • Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China.

ORCID-Profile: Kun Zheng, Jie Hao

Förderung

  • National Natural Science Foundation of China
  • Innovative Research Team of High-level Local Universities in Shanghai

Zitieren

APA

Xi, Y., Zheng, K., Deng, F., Liu, Y., Sun, H., Zheng, Y., Tong, H. H. Y., Ji, Y., Zhang, Y., Chen, W., Zhang, Y., Zou, X., & Hao, J. (2024). Themis: advancing precision oncology through comprehensive molecular subtyping and optimization. Briefings in Bioinformatics, 25(4). https://doi.org/10.1093/bib/bbae261

Vancouver

Xi Y, Zheng K, Deng F, Liu Y, Sun H, Zheng Y, et al. Themis: advancing precision oncology through comprehensive molecular subtyping and optimization. Briefings in Bioinformatics. 2024;25(4). doi:10.1093/bib/bbae261

BibTeX
@article{Xi2024,
  author = {Xi, Yue and Zheng, Kun and Deng, Fulan and Liu, Yujun and Sun, Hourong and Zheng, Yingxia and Tong, Henry H Y and Ji, Yuan and Zhang, Yingchun and Chen, Wantao and Zhang, Yiming and Zou, Xin and Hao, Jie},
  title = {Themis: advancing precision oncology through comprehensive molecular subtyping and optimization},
  journal = {Briefings in Bioinformatics},
  year = {2024},
  volume = {25},
  number = {4},
  doi = {10.1093/bib/bbae261}
}
Kostenlos starten →